γ-secretase directly sheds the survival receptor BCMA from plasma cells

Sarah Laurent(Ludwig-Maximilians-Universität München), Franziska Hoffmann(Ludwig-Maximilians-Universität München), Peer‐Hendrik Kuhn(German Center for Neurodegenerative Diseases), Qingyu Cheng(German Rheumatism Research Centre), Yuanyuan Chu(TUM Klinikum), Marc Schmidt‐Supprian(TUM Klinikum), Stefanie M. Hauck(Helmholtz Zentrum München), Elisabeth Schuh(Ludwig-Maximilians-Universität München), Markus Krumbholz(Ludwig-Maximilians-Universität München), Heike Rübsamen(Ludwig-Maximilians-Universität München), Johanna Wanngren(German Center for Neurodegenerative Diseases), Mohsen Khademi(Karolinska University Hospital), Tomas Olsson(Karolinska University Hospital), Tobias Alexander(German Rheumatism Research Centre), Falk Hiepe(German Rheumatism Research Centre), Hans‐Walter Pfister(Ludwig-Maximilians-Universität München), Frank Weber(Max Planck Institute of Psychiatry), Dieter E. Jenne(Helmholtz Zentrum München), Hartmut Wekerle(Munich Cluster for Systems Neurology), Reinhard Hohlfeld(Munich Cluster for Systems Neurology), Stefan F. Lichtenthaler(Munich Cluster for Systems Neurology), Edgar Meinl(Ludwig-Maximilians-Universität München)
Nature Communications
June 11, 2015
Cited by 358Open Access
Full Text

Abstract

Survival of plasma cells is regulated by B-cell maturation antigen (BCMA), a membrane-bound receptor activated by its agonist ligands BAFF and APRIL. Here we report that γ-secretase directly cleaves BCMA, without prior truncation by another protease. This direct shedding is facilitated by the short length of BCMA's extracellular domain. In vitro, γ-secretase reduces BCMA-mediated NF-κB activation. In addition, γ-secretase releases soluble BCMA (sBCMA) that acts as a decoy neutralizing APRIL. In vivo, inhibition of γ-secretase enhances BCMA surface expression in plasma cells and increases their number in the bone marrow. Furthermore, in multiple sclerosis, sBCMA levels in spinal fluid are elevated and associated with intracerebral IgG production; in systemic lupus erythematosus, sBCMA levels in serum are elevated and correlate with disease activity. Together, shedding of BCMA by γ-secretase controls plasma cells in the bone marrow and yields a potential biomarker for B-cell involvement in human autoimmune diseases.


Related Papers

No related papers found

Powered by citation graph analysis